WallStreetZenWallStreetZen

NASDAQ: ALLK
Allakos Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ALLK

Based on 3 analysts offering 12 month price targets for Allakos Inc.
Min Forecast
$1.00-5.66%
Avg Forecast
$1.83+72.92%
Max Forecast
$3.00+183.02%

Should I buy or sell ALLK stock?

Based on 3 analysts offering ratings for Allakos Inc.
Hold
Strong Buy
0 analysts 0%
Buy
1 analysts 33.33%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
1 analysts 33.33%

Be the first to know when Wall Street analysts revise their ALLK stock forecasts and price targets.

ALLK stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-01-17
lockedlocked$00.00+00.00%2024-01-17
lockedlocked$00.00+00.00%2024-01-17

1 of 1

Forecast return on equity

Is ALLK forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.66%

Forecast return on assets

Is ALLK forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

ALLK revenue forecast

What is ALLK's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$32.6M
Avg 2 year Forecast
$59.9M
Avg 3 year Forecast
$378.0M

ALLK vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ALLK$1.06$1.83+72.92%Hold
RNAC$17.28$51.00+195.14%Buy
ARMP$2.55$7.00+174.51%Buy
DMAC$2.49$7.00+181.12%Buy
CRIS$15.22$26.00+70.83%Strong Buy
View Top Biotech Stocks

Allakos Stock Forecast FAQ

Is Allakos Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: ALLK) stock is to Hold ALLK stock.

Out of 3 analysts, 0 (0%) are recommending ALLK as a Strong Buy, 1 (33.33%) are recommending ALLK as a Buy, 1 (33.33%) are recommending ALLK as a Hold, 0 (0%) are recommending ALLK as a Sell, and 1 (33.33%) are recommending ALLK as a Strong Sell.

If you're new to stock investing, here's how to buy Allakos stock.

What is ALLK's revenue growth forecast for 2026-2028?

(NASDAQ: ALLK) Allakos's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.23%.

Allakos's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast ALLK's revenue for 2026 to be $2,868,207,197, with the lowest ALLK revenue forecast at $2,868,207,197, and the highest ALLK revenue forecast at $2,868,207,197. On average, 2 Wall Street analysts forecast ALLK's revenue for 2027 to be $5,266,727,890, with the lowest ALLK revenue forecast at $3,014,078,029, and the highest ALLK revenue forecast at $7,519,377,752.

In 2028, ALLK is forecast to generate $33,211,976,410 in revenue, with the lowest revenue forecast at $33,211,976,410 and the highest revenue forecast at $33,211,976,410.

What is ALLK's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ALLK) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is ALLK's Price Target?

According to 3 Wall Street analysts that have issued a 1 year ALLK price target, the average ALLK price target is $1.83, with the highest ALLK stock price forecast at $3.00 and the lowest ALLK stock price forecast at $1.00.

On average, Wall Street analysts predict that Allakos's share price could reach $1.83 by Jan 17, 2025. The average Allakos stock price prediction forecasts a potential upside of 72.92% from the current ALLK share price of $1.06.

What is ALLK's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ALLK) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.